HKAPI is pleased to announce its new associate members Avalon SteriTech, Fosun International Limited and ZP Therapeutics, which have newly joined our association in the first quarter of 2021.
The HKAPI held its online Annual General Meeting on March 24.
The Board members presented reports on work over the past year, and unveiled its revamped web site for members.
The Greater Bay Area development has taken centre stage in Hong Kong Policy Address 2020. To facilitate members taking business opportunities in GBA, HKAPI jointly organized a virtual training with the Shenzhen Hospital Manager Association in November and December 2020.
The HKAPI Medical Representatives Training Programme has been completed. This year, 63 students are qualified to take the examination. with 7 of them achieving distinction.
In its Extraordinary General Meeting held on 4 November 2020, the HKAPI has passed a motion to adopt a set of Guidance on Virtual Engagements with Health Care Professionals to address the situations involving the provision of meals during virtual conferences and
Our task force leads Karen Yuen and Sui Wong joined the “World Rare Disease Day 2020 Online Symposium” organized by Rare Disease Hong Kong (RDHK), formerly known as “Hong Kong Alliance for Rare Diseases (HKARD)”.
HKAPI submits an opinion paper, on behalf of its 33 member companies engaging in the research and development of novel pharmaceuticals, and providing 70% of treatment drugs in Hong Kong.
The Hong Kong Association of The Pharmaceutical Industry (HKAPI) held its Annual General Meeting on 2 April 2020 and delighted to announce the formation of the New Board (2020 – 2022).